![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 8
2021
Gosewisch, Astrid; Schleske, M.; Gildehaus, F. J.; Berg, I.; Kaiser, L.; Brosch, J.; Bartenstein, P.; Todica, A.; Ilhan, Harun und Böning, G.
(2021):
Image-based dosimetry for 225Ac-PSMA-I&T therapy using quantitative SPECT.
In: European journal of nuclear medicine and molecular imaging, Bd. 48, Nr. 4: S. 1260-1261
[PDF, 303kB]
Beyer, Leonie; Gosewisch, Astrid; Lindner, Simon; Völter, Friederike; Mittlmeier, Lena M.; Tiling, Reinhold; Brendel, Matthias; Cyran, Clemens C.; Unterrainer, Marcus; Rübenthaler, Johannes; Auernhammer, Christoph J.; Spitzweg, Christine; Böning, Guido; Gildehaus, F. J.; Jurkschat, Klaus; Wängler, Carmen; Wängler, Björn; Schirrmacher, Ralf; Wenter, Vera; Todica, Andrei; Bartenstein, Peter und Ilhan, Harun
(2021):
Dosimetry and optimal scan time of 18FSiTATE-PET/CT in patients with neuroendocrine tumours.
In: European journal of nuclear medicine and molecular imaging, Bd. 48: S. 3571-3581
[PDF, 2MB]
Beyer, Leonie; Gosewisch, Astrid; Lindner, Simon; Voelter, Friederike; Mittlmeier, Lena M.; Tiling, Reinhold; Brendel, Matthias; Cyran, Clemens C.; Unterrainer, Marcus; Ruebenthaler, Johannes; Auernhammer, Christoph J.; Spitzweg, Christine; Boening, Guido; Gildehaus, F. J.; Jurkschat, Klaus; Wangler, Carmen; Wangler, Bjoern; Schirrmacher, Ralf; Wenter, Vera; Todica, Andrei; Bartenstein, Peter und Ilhan, Harun
(2021):
Dosimetry and optimal scan time of [F-18]SiTATE-PET/CT in patients with neuroendocrine tumours.
In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 48, Nr. 11: S. 3571-3581
2020
Ilhan, Harun; Lindner, S.; Todica, A.; Cyran, C. C.; Tiling, R.; Auernhammer, C. J.; Spitzweg, C.; Boeck, S.; Unterrainer, M.; Gildehaus, F. J.; Böning, G.; Jurkschat, K.; Wängler, C.; Wängler, B.; Schirrmacher, R. und Bartenstein, P.
(2020):
Biodistribution and first clinical results of F-18-SiFAlin-TATE PET: a novel F-18-labeled somatostatin analog for imaging of neuroendocrine tumors.
In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 47, Nr. 4: S. 870-880
2019
Rudisile, S.; Gosewisch, A.; Wenter, V; Unterrainer, M.; Boening, G.; Gildehaus, F. J.; Fendler, W. P.; Auernhammer, C. J.; Spitzweg, C.; Bartenstein, P.; Todica, A. und Ilhan, H.
(2019):
Salvage PRRT with Lu-177-DOTA-octreotate in extensively pretreated patients with metastatic neuroendocrine tumor (NET): dosimetry, toxicity, efficacy, and survival.
In: BMC Cancer, Bd. 19, Nr. 1, 788
2018
Fiedler, L.; Kellner, M.; Gosewisch, A.; Oos, R.; Boening, G.; Lindner, S.; Albert, Nathalie L. 
ORCID: https://orcid.org/0000-0003-0953-7624; Bartenstein, P.; Reulen, H.-J.; Zeidler, R. und Gildehaus, F. J.
(2018):
Evaluation of Lu-177[Lu]-CHX-A ''-DTPA-6A10 Fab as a radioimmunotherapy agent targeting carbonic anhydrase XII.
In: Nuclear Medicine and Biology, Bd. 60: S. 55-62
ORCID: https://orcid.org/0000-0003-0953-7624; Bartenstein, P.; Reulen, H.-J.; Zeidler, R. und Gildehaus, F. J.
(2018):
Evaluation of Lu-177[Lu]-CHX-A ''-DTPA-6A10 Fab as a radioimmunotherapy agent targeting carbonic anhydrase XII.
In: Nuclear Medicine and Biology, Bd. 60: S. 55-62
2016
Gosewisch, A.; Delker, A.; Tattenberg, S.; Vomacka, L.; Gildehaus, F. J.; Brunegraf, A.; Bartenstein, P. und Boening, G.
(2016):
Investigation of a hybrid image approach and a reduction in the number of blood samples for a decreased clinical workload for patient-specific bone marrow dosimetry in Lu-177-DKFZ-PSMA-617 therapy.
In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 43:
S415-S415
2015
Reulen, H. J.; Poepperl, G.; Goetz, C.; Gildehaus, F. J.; Schmidt, M.; Tatsch, K.; Pietsch, T.; Kraus, T. und Rachinger, W.
(2015):
Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy.
In: Journal of Neurosurgery (JNS), Bd. 123, Nr. 3: S. 760-770